Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

A comparison of visual and semiquantitative analysis methods for planar cardiac 123I-MIBG scintigraphy in dementia with Lewy bodies.

Roberts G, Kane JPM, Lloyd JJ, Petrides GS, Howe K, O'Brien JT, Thomas AJ.

Nucl Med Commun. 2019 Jul;40(7):734-743. doi: 10.1097/MNM.0000000000001024.

PMID:
31058746
2.

Potential diagnostic value of 131I-MIBG myocardial scintigraphy in discrimination between Alzheimer disease and dementia with Lewy bodies.

Abbasi M, Ghalandari N, Farzanefar S, Aghamollaii V, Ahmadi M, Ganji M, Afarideh M, Loloee S, Naseri M, Tafakhori A.

Clin Neurol Neurosurg. 2017 Dec;163:163-166. doi: 10.1016/j.clineuro.2017.10.024. Epub 2017 Oct 25.

PMID:
29112909
3.

123I-MIBG scintigraphy utility and cut-off value in a clinically representative dementia cohort.

Kane JPM, Roberts G, Petrides GS, Lloyd JJ, O'Brien JT, Thomas AJ.

Parkinsonism Relat Disord. 2019 May;62:79-84. doi: 10.1016/j.parkreldis.2019.01.024. Epub 2019 Jan 26.

PMID:
30709778
4.

[Diagnostic value of cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in Lewy body disorders].

Escamilla-Sevilla F, Pérez-Navarro MJ, Muñoz-Pasadas M, Ortega-Léon T, Gallego-Peinado M, Cabello-García D, Gómez Río M, Ortega-Moreno A, Carnero-Pardo C, Rebollo-Aguirre AC, Mínguez-Castellanos A.

Neurologia. 2009 Apr;24(3):170-6. Spanish.

PMID:
19418293
5.

Quantification and Determination of Normal 123I-Meta Iodobenzylguanidine Heart-to-Mediastinum Ratio (HMR) from Cardiac SPECT/CT and Correlation with Planar HMR.

Alvi R, Miller EJ, Zonouz TH, Sandoval V, Tariq N, Lampert R, Sinusas AJ, Liu YH.

J Nucl Med. 2018 Apr;59(4):652-658. doi: 10.2967/jnumed.117.197152. Epub 2017 Sep 15.

6.

Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study.

Yoshita M, Arai H, Arai H, Arai T, Asada T, Fujishiro H, Hanyu H, Iizuka O, Iseki E, Kashihara K, Kosaka K, Maruno H, Mizukami K, Mizuno Y, Mori E, Nakajima K, Nakamura H, Nakano S, Nakashima K, Nishio Y, Orimo S, Samuraki M, Takahashi A, Taki J, Tokuda T, Urakami K, Utsumi K, Wada K, Washimi Y, Yamasaki J, Yamashina S, Yamada M.

PLoS One. 2015 Mar 20;10(3):e0120540. doi: 10.1371/journal.pone.0120540. eCollection 2015.

7.

[Dementia with Lewy bodies and Alzheimer's disease: differential diagnosis by cardiac sympathetic innervation MIBG imaging].

Estorch M, Camacho V, Fuertes J, Rodríguez-Revuelto A, Hernández MA, Flotats A, Kulisevsky J, Carrió I.

Rev Esp Med Nucl. 2006 Jul-Aug;25(4):229-35. Spanish.

PMID:
16827985
8.

[Early alteration of adrenergic cardiac function in parkinsonisms with Lewy bodies].

Jiménez-Hoyuela García JM, Campos Arillo V, Rebollo Aguirre AC, Gómez Doblas JJ, Gutiérrez Hurtado A.

Rev Esp Med Nucl. 2005 Mar-Apr;24(2):93-100. Spanish.

PMID:
15745679
9.

123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies.

Manabe Y, Inui Y, Toyama H, Kosaka K.

Psychiatry Res Neuroimaging. 2017 Mar 30;261:75-79. doi: 10.1016/j.pscychresns.2016.12.011. Epub 2017 Jan 20.

PMID:
28152401
10.

[Utility of early imaging of myocardial innervation scintigraphy in the diagnosis of Lewy Body Dementia].

Camacho V, Estorch M, Marquié M, Domènech A, Flotats A, Fernández A, Duch J, Geraldo LL, Deportos J, Artigas C, Lleó A, Carrió I.

Rev Esp Med Nucl Imagen Mol. 2013 Mar;32(2):77-80. doi: 10.1016/j.remn.2012.03.012. Epub 2012 May 18. Spanish.

PMID:
23177334
11.

Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders.

King AE, Mintz J, Royall DR.

Mov Disord. 2011 Jun;26(7):1218-24. doi: 10.1002/mds.23659. Epub 2011 Apr 7.

PMID:
21480373
12.

High-speed scanning of planar images showing 123I-MIBG uptake using a whole-body CZT camera: a phantom and clinical study.

Okano N, Osawa I, Tsuchihashi S, Takahashi M, Niitsu M, Matsunari I.

EJNMMI Res. 2019 Feb 26;9(1):22. doi: 10.1186/s13550-019-0491-z.

13.

On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases.

Odagiri H, Baba T, Nishio Y, Iizuka O, Matsuda M, Inoue K, Kikuchi A, Hasegawa T, Aoki M, Takeda A, Taki Y, Mori E.

PLoS One. 2016 Apr 7;11(4):e0152746. doi: 10.1371/journal.pone.0152746. eCollection 2016.

14.

Potential diagnostic value of regional myocardial adrenergic imaging using (123)I-MIBG SPECT to identify patients with Lewy body diseases.

Lebasnier A, Lamotte G, Manrique A, Peyronnet D, Bouvard G, Defer G, Agostini D.

Eur J Nucl Med Mol Imaging. 2015 Jun;42(7):1043-51. doi: 10.1007/s00259-015-2989-6. Epub 2015 Jan 28.

PMID:
25626701
15.

Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies.

Camacho V, Marquié M, Lleó A, Alvés L, Artigas C, Flotats A, Duch J, Blesa R, Gómez-Isla T, Carrió I, Estorch M.

Q J Nucl Med Mol Imaging. 2011 Aug;55(4):476-83. Epub 2010 Dec 9.

PMID:
21150861
16.

Comparison of the diagnostic performance of H/M ratio between early and delayed phases for Lewy body disease.

Maruyama Y, Yamada T, Murakami K, Kumano R.

Nucl Med Commun. 2015 May;36(5):477-80. doi: 10.1097/MNM.0000000000000271.

17.

Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis.

Slaets S, Van Acker F, Versijpt J, Hauth L, Goeman J, Martin JJ, De Deyn PP, Engelborghs S.

Int J Geriatr Psychiatry. 2015 Aug;30(8):864-9. doi: 10.1002/gps.4229. Epub 2014 Nov 3.

18.

Uptake Index of 123I-metaiodobenzylguanidine Myocardial Scintigraphy for Diagnosing Lewy Body Disease.

Kamiya Y, Ota S, Okumiya S, Yamashita K, Takaki A, Ito S.

Asia Ocean J Nucl Med Biol. 2017 Winter;5(1):37-43. doi: 10.22038/aojnmb.2016.7972.

19.

Is 123I-metaiodobenzylguanidine heart-to-mediastinum ratio dependent on age? From Japanese Society of Nuclear Medicine normal database.

Nakajima K, Okuda K, Matsuo S, Wakabayashi H, Kinuya S.

Ann Nucl Med. 2018 Apr;32(3):175-181. doi: 10.1007/s12149-018-1231-6. Epub 2018 Jan 15.

20.

¹²³I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activity.

Verschure DO, de Wit TC, Bongers V, Hagen PJ, Sonneck-Koenne C, D'Aron J, Huber K, van Eck-Smit BL, Knoll P, Somsen GA, Mirzaei S, Verberne HJ.

Nucl Med Commun. 2015 Mar;36(3):279-85. doi: 10.1097/MNM.0000000000000238.

PMID:
25415845

Supplemental Content

Support Center